English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  50614972    ???header.onlineuser??? :  905
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

???jsp.browse.items-by-title.jump??? [ ???jsp.browse.general.jump2chinese??? ] [ ???jsp.browse.general.jump2numbers??? ] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
???jsp.browse.items-by-title.enter???   

Showing items 542651-542675 of 2347237  (93890 Page(s) Totally)
<< < 21702 21703 21704 21705 21706 21707 21708 21709 21710 21711 > >>
View [10|25|50] records per page

Institution Date Title Author
中國醫藥大學 2011-12 Lapatinib Induces Autophagy, Apoptosis and Megakaryocytic Differentiation in Chronic Myelogenous Leukemia K562 Cells (Huey-Lan Huang);(Yu-Chieh Chen);黃毓銓(Yu-Chuen Huang);(Kai-Chien Yang);(Hsin yi Pan);(Shou-Ping Shih);陳裕仁(Yu-Jen Chen)*
臺大學術典藏 2021-05-07T06:48:04Z Lapatinib induces autophagy, apoptosis and megakaryocytic differentiation in chronic myelogenous leukemia K562 cells Huang H.-L.; Chen Y.-C.; Huang Y.-C.; KAI-CHIEN YANG; Pan H.y.; Shih S.-P.; Chen Y.-J.
中國醫藥大學 2014-05-27 Lapatinib induces IL-6 expression via MAPK pathway in triple-negative breast cancer cells 蕭宇君(Hsiao Yu-Chun);陳孟良(Mong-Liang Chen);陳韻如(Chen Yun-Ju);湯智昕(Tang Chih-Hsin);黃偉謙(Wei-Chien Huang)*
臺大學術典藏 2018-09-10T14:52:06Z Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN - A randomized, phase III study KUN-HUEI YEH; Satoh, T. and Doi, T. and Ohtsu, A. and Tsuji, A. and Omuro, Y. and Mukaiyama, A. and Kobayashi, M. and Miwa, H. and Xu, R.-H. and Sun, G.-P. and Xu, J.-M. and Wang, J.-W. and Li, J. and Qin, S.-K. and Feng, J.-F. and Chung, H.C. and Bang, Y.-J. and Chung, I.-J. and Yeh, K.-H.
臺大學術典藏 2021-01-28T01:06:31Z Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN - A randomized, phase III study Satoh T.;Doi T.;Ohtsu A.;Tsuji A.;Omuro Y.;Mukaiyama A.;Kobayashi M.;Miwa H.;Xu R.-H.;Sun G.-P.;Xu J.-M.;Wang J.-W.;Li J.;Qin S.-K.;Feng J.-F.;Chung H.C.;Bang Y.-J.;Chung I.-J.;Kun-Huei Yeh; Satoh T.; Doi T.; Ohtsu A.; Tsuji A.; Omuro Y.; Mukaiyama A.; Kobayashi M.; Miwa H.; Xu R.-H.; Sun G.-P.; Xu J.-M.; Wang J.-W.; Li J.; Qin S.-K.; Feng J.-F.; Chung H.C.; Bang Y.-J.; Chung I.-J.; KUN-HUEI YEH
國立成功大學 2012-02-18 Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial Baselga, Jose; Bradbury, Ian; Eidtmann, Holger; Di Cosimo, Serena; de Azambuja, Evandro; Aura, Claudia; Gomez, Henry; Dinh, Phuong; Fauria, Karine; Van Dooren, Veerle; Aktan, Gursel; Goldhirsch, Aron; Chang, Tsai-Wang; Horvath, Zsolt; Coccia-Portugal, Maria; Domont, Julien; Tseng, Ling-Min; Kunz, Georg; Sohn, Joo Hyuk; Semiglazov, Vladimir; Lerzo, Guillermo; Palacova, Marketa; Probachai, Volodymyr; Pusztai, Lajos; Untch, Michael; Gelber, Richard D.; Piccart-Gebhart, Martine
國立臺灣大學 2014 Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response de Azambuja, Evandro; Holmes, Andrew P.; Piccart-Gebhart, Martine; Holmes, Eileen; Di Cosimo, Serena; Swaby, Ramona F.; Untch, Michael; Jackisch, Christian; Lang, Istvan; Smith, Ian; Boyle, Frances; Xu, Binghe; Barrios, Carlos H.; Perez, Edith A.; Azim, Hatem A., Jr.; Kim, Sung-Bae; Kuemmel, Sherko; Huang, Chiun-Sheng; Vuylsteke, Peter; Hsieh, Ruey-Kuen; Gorbunova, Vera; Eniu, Alexandru; Dreosti, Lydia; Tavartkiladze, Natalia; Gelber, Richard D.; Eidtmann, Holger; Baselga, Jose; 黃俊升
臺大學術典藏 2018-09-10T15:02:13Z Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response de Azambuja, E. and Holmes, A.P. and Piccart-Gebhart, M. and Holmes, E. and Di Cosimo, S. and Swaby, R.F. and Untch, M. and Jackisch, C. and Lang, I. and Smith, I. and Boyle, F. and Xu, B. and Barrios, C.H. and Perez, E.A. and Azim, H.A. and Kim, S.-B. and Kuemmel, S. and Huang, C.-S. and Vuylsteke, P. and Hsieh, R.-K. and Gorbunova, V. and Eniu, A. and Dreosti, L. and Tavartkiladze, N. and Gelber, R.D. and Eidtmann, H. and Baselga, J.; CHIUN-SHENG HUANG
臺大學術典藏 2020-03-23T07:19:13Z Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): Survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response Xu B.; Boyle F.; Smith I.; Jackisch C.; Lang I.; Untch M.; Swaby R.F.; Di Cosimo S.; Holmes E.; Piccart-Gebhart M.; Holmes A.P.; De Azambuja E.;Holmes A.P.;Piccart-Gebhart M.;Holmes E.;Di Cosimo S.;Swaby R.F.;Untch M.;Jackisch C.;Lang I.;Smith I.;Boyle F.;Xu B.;Barrios C.H.;Perez E.A.;Azim H.A.;Kim S.-B.;Kuemmel S.;Chiun-Sheng Huang;Vuylsteke P.;Hsieh R.-K.;Gorbunova V.;Eniu A.;Dreosti L.;Tavartkiladze N.;Gelber R.D.;Eidtmann H.;Baselga J.; De Azambuja E.; Barrios C.H.; Perez E.A.; Azim H.A.; Kim S.-B.; Kuemmel S.; CHIUN-SHENG HUANG; Vuylsteke P.; Hsieh R.-K.; Gorbunova V.; Eniu A.; Dreosti L.; Tavartkiladze N.; Gelber R.D.; Eidtmann H.; Baselga J.
中國醫藥大學 2013-12-31 Lapatinib 脫靶效應增強HDAC抑制劑對三陰性乳癌治療效果之探討 葉名焮(Ming-Hsin, Alex, Yeh);黃偉謙(Wei-Chien Huang)
中國醫藥大學 2013-11 Lapatinib-induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors (Yun-Ju Chen);葉名焮(Ming-Hsin, Alex, Yeh);游孟潔(Meng-Chieh Yu);魏雅鈴(Ya-Ling Wei);(Wen-Shu Chen);(Jhen-Yu Chen);(Chih-Yu Shih);涂智彥(Chih-Yen Tu);陳家弘(Chia-Hung Chen);夏德椿(Te-Chun Hsia);(Pei-Hsuan Chien);(Shu-Hui Liu);余永倫(Yung-Luen Yu);黃偉謙(Wei-Chien Huang)*
亞洲大學 2013 Lapatinib-mediated COX-2 expression via EGFR/HuR interaction enhances the aggressiveness of triple-negative breast cancer cells Hsia, Te-Chun;Hsia, Te-Chun;Hsia, Te-Chun;Hsia, Te-Chun;Chen, Yun-Ju;Chen, Yun-Ju;Wei, Ya-Ling;Wei, Ya-Ling;Meng-Chieh, Y;Yu, Meng-Chieh;Sheng-Chie, H;Hsu, Sheng-Chie;Shing-Ling, T;Tsai, Shing-Ling;Chen, Wen-Shu;Chen, Wen-Shu;Ming-Hsin, Alex, Yeh,;余永倫;Yu, Yung-luen;Hua, Tzungchi;Huang, Tzungchi;Hu, Chih-Yang;Huang, Chih-Yang;Hu, Mien-Chie;Hung, Mien-Chie
義守大學 2013-04 Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells Te-Chun Hsia;Chih-Yen Tu;Yun-Ju Chen;Ya-Ling Wei;Meng-Chieh Yu;Sheng-Chie Hsu;Shing-Ling Tsai;Wen-Shu Chen;Ming-Hsin Yeh;Chia-Jui Yen;Yung-Luen Yu;Tzung-Chi Huang;Chih-Yang Huang;Mien-Chie Hung;Wei-Chien Huang
國立成功大學 2013-04 Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells Hsia, Te-Chun; Tu, Chih-Yen; Chen, Yun-Ju; Wei, Ya-Ling; Yu, Meng-Chieh; Hsu, Sheng-Chie; Tsai, Shing-Ling; Chen, Wen-Shu; Yeh, Ming-Hsin; Yen, Chia-Jui; Yu, Yung-Luen; Huang, Tzung-Chi; Huang, Chih-Yang; Hung, Mien-Chie; Huang, Wei-Chien
中國醫藥大學 2013-09-28 Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells 夏德椿(Te-Chun Hsia);涂智彥(Chih-Yen Tu);陳韻如(Yun-Ju Chen);魏雅鈴(Ya-Ling Wei);黃偉謙(Wei-Chien Huang)
中國醫藥大學 2015-06-29 Lapatinibenhances migration ability of triple-negative breast cancer cells through induction of Raf-1/MAPK-dependent interleukin-6 expression by downergulationof microRNA-7 蕭宇君(Yu-Chun Hsiao);陳韻如(Yun-Ju Chen);黃偉謙(Wei-Chien Huang);黃偉謙(Wei-Chien Huang)
義守大學 2013-11 Lapatinib–induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors Yun-Ju Chen;Ming-Hsin Yeh;Meng-Chieh Yu;Ya-Ling Wei;Wen-Shu Chen;Jhen-Yu Chen;Chih-Yu Shih;Chih-Yen Tu;Chia-Hung Chen;Te-Chun Hsia;Pei-Hsuan Chien;Shu-Hui Liu;Yung-Luen Yu;Wei-Chien Huang
中國醫藥大學 2013-09-28 Lapatinib–induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors 游孟潔(Meng-Chieh Yu);陳韻如(Yun-Ju Chen);葉名焮(Ming-Hsin, Alex, Yeh);魏雅鈴(Ya-Ling Wei);黃偉謙(Wei-Chien Huang)
國立成功大學 2011-07-16 Laplace Adomian 混合分解法應用於邊界層流流經楔型板之研究 陳柏維; Chen, Po-Wei
國立成功大學 2011-06-15 Laplace Adomian 混合分解法應用於邊界層流流經楔型板之研究 陳柏維; Chen, Po-Wei
國立成功大學 2010-01-21 Laplace Adomian 混合分解法應用於非線性物理系統之研究 蔡培毅; Tsai, Pa-Yee
國立成功大學 2010-01-21 Laplace Adomian 混合分解法應用於非線性物理系統之研究 蔡培毅; Tsai, Pa-Yee
國立成功大學 2014-07-22 Laplace Adomian混合分解法應用於非線性熱傳問題之研究 張又升; Chang, Yu-Sheng
國立成功大學 2014-06-26 Laplace Adomian混合分解法應用於非線性熱傳問題之研究 張又升; Chang, Yu-Sheng
國立交通大學 2015-07-21T08:29:25Z Laplace Group Sensing for Acoustic Models Chien, Jen-Tzung

Showing items 542651-542675 of 2347237  (93890 Page(s) Totally)
<< < 21702 21703 21704 21705 21706 21707 21708 21709 21710 21711 > >>
View [10|25|50] records per page